DFX Intelligence
Data Factory
Reading the graph
Reading the graph
加科思药业(1167.HK)致力于为患者提供突破性治疗方案。公司在研项目围绕KRAS、肿瘤免疫、肿瘤代谢、P53、RB、MYC六大肿瘤信号通路布局，核心项目以全球前三为目标。公司的愿景是与合作伙伴携手共进，成为全球认可的药物研发领导者。加科思的实验室坐落于中国北京、上海和美国波士顿，拥有诱导变构药物发现平台和iADC药物研发平台。
Data as of (this record's last observation) from Sworn filings; Announcements; Limited partners. Page built and rebuilt at most every 15 minutes.
This entity has not been resolved onto another DFX graph by a shared identifier. A name match elsewhere would be a candidate, never an identity, and none is recorded.
| Investor | Class | Fund | Partner | Role | Attribution |
|---|---|---|---|---|---|
| Qiming Global Management, LLC | Institutional VC | n/a | n/a | unknown | Unknown |
| Qiming U.S. Ventures Management, LLC | Institutional VC | n/a | n/a | unknown | Unknown |